Citadel Advisors’s Rockwell Medical RMTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.6K | Buy |
+1,300
| New | +$12.9K | ﹤0.01% | 12740 |
|
|
2025
Q3 | – | Sell |
-1,040
| Closed | -$8.82K | – | 13888 |
|
|
2025
Q2 | $8.82K | Sell |
1,040
-450
| -30% | -$4.59K | ﹤0.01% | 12203 |
|
|
2025
Q1 | $16.8K | Sell |
1,490
-230
| -13% | -$4.17K | ﹤0.01% | 13266 |
|
|
2024
Q4 | $35.1K | Buy |
1,720
+1,030
| +149% | +$30K | ﹤0.01% | 12731 |
|
|
2024
Q3 | $27.4K | Buy |
690
+510
| +283% | +$13.7K | ﹤0.01% | 12515 |
|
|
2024
Q2 | $3.17K | Sell |
180
-1,430
| -89% | -$24.2K | ﹤0.01% | 13619 |
|
|
2024
Q1 | $26.7K | Buy |
1,610
+1,010
| +168% | +$14.7K | ﹤0.01% | 12794 |
|
|
2023
Q4 | $11.3K | Sell |
600
-3,310
| -85% | -$62.2K | ﹤0.01% | 13046 |
|
|
2023
Q3 | $81.3K | Buy |
3,910
+2,300
| +143% | +$69.9K | ﹤0.01% | 11158 |
|
|
2023
Q2 | $87.9K | Buy |
1,610
+1,370
| +571% | +$42.1K | ﹤0.01% | 11122 |
|
|
2023
Q1 | $4.34K | Buy |
240
+210
| +700% | +$3.62K | ﹤0.01% | 13962 |
|
|
2022
Q4 | $305 | Buy |
+30
| New | +$321 | ﹤0.01% | 14698 |
|
|
2021
Q4 | – | Sell |
-149
| Closed | -$10K | – | 14603 |
|
|
2021
Q3 | $10K | Sell |
149
-35
| -19% | -$2.65K | ﹤0.01% | 13684 |
|
|
2021
Q2 | $18K | Sell |
184
-248
| -57% | -$25.6K | ﹤0.01% | 13544 |
|
|
2021
Q1 | $55K | Buy |
+432
| New | +$63.9K | ﹤0.01% | 12859 |
|
|
2020
Q4 | – | Sell |
-545
| Closed | -$64K | – | 11429 |
|
|
2020
Q3 | $64K | Buy |
545
+135
| +33% | +$23.4K | ﹤0.01% | 9504 |
|
|
2020
Q2 | $88K | Buy |
410
+49
| +14% | +$11.6K | ﹤0.01% | 9065 |
|
|
2020
Q1 | $81K | Buy |
+361
| New | +$103K | ﹤0.01% | 8777 |
|
|
2019
Q3 | – | Sell |
-155
| Closed | -$51K | – | 9671 |
|
|
2019
Q2 | $51K | Sell |
155
-58
| -27% | -$29.5K | ﹤0.01% | 8725 |
|
|
2019
Q1 | $133K | Sell |
213
-148
| -41% | -$67.5K | ﹤0.01% | 8438 |
|
|
2018
Q4 | $90K | Sell |
361
-257
| -42% | -$102K | ﹤0.01% | 8285 |
|
|
2018
Q3 | $287K | Buy |
618
+157
| +34% | +$76K | ﹤0.01% | 7641 |
|
|
2018
Q2 | $250K | Buy |
461
+121
| +36% | +$72.6K | ﹤0.01% | 7527 |
|
|
2018
Q1 | $195K | Buy |
340
+187
| +122% | +$118K | ﹤0.01% | 7370 |
|
|
2017
Q4 | $98K | Sell |
153
-27
| -15% | -$19K | ﹤0.01% | 7445 |
|
|
2017
Q3 | $169K | Sell |
180
-477
| -73% | -$365K | ﹤0.01% | 6801 |
|
|
2017
Q2 | $573K | Buy |
657
+388
| +144% | +$318K | ﹤0.01% | 4928 |
|
|
2017
Q1 | $185K | Buy |
269
+76
| +39% | +$50.1K | ﹤0.01% | 6579 |
|
|
2016
Q4 | $139K | Sell |
193
-434
| -69% | -$300K | ﹤0.01% | 6541 |
|
|
2016
Q3 | $462K | Sell |
627
-437
| -41% | -$354K | ﹤0.01% | 4985 |
|
|
2016
Q2 | $886K | Buy |
1,064
+218
| +26% | +$203K | ﹤0.01% | 3713 |
|
|
2016
Q1 | $699K | Buy |
846
+567
| +203% | +$445K | ﹤0.01% | 3935 |
|
|
2015
Q4 | $314K | Sell |
279
-247
| -47% | -$287K | ﹤0.01% | 5154 |
|
|
2015
Q3 | $446K | Buy |
526
+47
| +10% | +$68.1K | ﹤0.01% | 4965 |
|
|
2015
Q2 | $850K | Buy |
479
+257
| +116% | +$327K | ﹤0.01% | 4189 |
|
|
2015
Q1 | $267K | Sell |
222
-289
| -57% | -$338K | ﹤0.01% | 5821 |
|
|
2014
Q4 | $578K | Buy |
511
+6
| +1% | +$6.15K | ﹤0.01% | 4516 |
|
|
2014
Q3 | $507K | Buy |
505
+260
| +106% | +$294K | ﹤0.01% | 4602 |
|
|
2014
Q2 | $323K | Sell |
245
-57
| -19% | -$68.6K | ﹤0.01% | 4970 |
|
|
2014
Q1 | $420K | Sell |
302
-26
| -8% | -$33.8K | ﹤0.01% | 4603 |
|
|
2013
Q4 | $377K | Sell |
328
-305
| -48% | -$420K | ﹤0.01% | 4352 |
|
|
2013
Q3 | $794K | Buy |
633
+317
| +100% | +$215K | ﹤0.01% | 3331 |
|
|
2013
Q2 | $126K | Buy |
+316
| New | +$134K | ﹤0.01% | 5052 |
|
Other funds holding RMTI
VCM
VFT
WANY
Citadel Advisors's RMTI Position: Q1 2026 in Review
Citadel Advisors sold out of Rockwell Medical (RMTI) in Q1 2026, closing a stake of 8,189 shares — an estimated $81.6K sold.
Citadel Advisors first reported a position in RMTI in Q2 2013 and held it in 41 quarters. The position peaked at $772K in Q4 2014. 42 funds tracked by Wall St. Rank hold RMTI as of Q1 2026.
- Citadel Advisors reported no remaining Rockwell Medical position as of Q1 2026 after selling out during the quarter.
- Citadel Advisors sold 8,189 Rockwell Medical shares in Q1 2026, an estimated $81.6K.
- Citadel Advisors first reported a position in Rockwell Medical in Q2 2013 and held it in 41 quarters.
- Citadel Advisors's Rockwell Medical position peaked at $772K in Q4 2014.
- 42 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.